FOFleur O'HAre

Fleur O'HAre

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fleur O'HAre has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Community‐Led Approach to Enhancing Informed Consent for Individuals With Vision Impairment

    by Fleur O'HAre, David Foran, Tessa Saunders, Lisa Eckstein, Gudrun Wells, Daniel Talko, Kevin Lee, Shane Somerville, Debra Simons, Grace King, et al.

    Participant Information and Consent Forms (PICFs) are critical documents that help promote informed decision‐making about research participation. However, many PICFs remain inaccessible to people with diverse needs, including those experiencing print disability. Providing information in multiple accessible formats can enhance inclusivity and support equitable access to research opportunities. The “Meeting Access and Inclusion Needs” (MAIN) project was a four‐part, community‐engaged, formative study employing qualitative research methods. Part 1 involved focus groups with eight disability advocacy organizations ( n = 21 individuals) to identify accessibility requirements. Part 2 comprised a co‐design workshop series ( n = 11 participants with lived experience) to develop accessible PICF templates. Part 3 included individual user experience sessions ( n = 6 participants) employing the think‐aloud methodology and the Theoretical Framework of Acceptability questionnaire. Part 4 involved an independent accessibility audit by Vision Australia against digital accessibility standards. The MAIN Project resulted in three co‐designed PICF formats (print, audio, and video). The co‐design team emphasized that two to three format options were essential, with one participant noting: “Everyone's need is unique, and accessibility is about more options for more people.” The accessibility audit confirmed all templates met standards with minor modifications (e.g., metadata additions, caption pixelation resolution, text color adjustment). All templates conformed with accessibility standards and best practice guidelines following final revisions. Community‐engaged co‐design successfully produced formative, accessible, multi‐format PICF templates meeting accessibility standards. Offering two to three information formats enhances accessibility and supports inclusive research participation. These templates and accompanying guidelines provide researchers with practical resources to tailor informed consent processes to diverse needs, particularly for people with vision impacts. Further research should focus on large‐scale implementation and evaluation across research settings and populations.


  • Open Access

    Accessible informed consent: A mixed methods study of Australian clinical research staff perspectives

    by Fleur O’HAre, Camille Paynter, David Foran, Kelly Schulz, Myra B. McGuinness, Lauren Barina, Steven Y. C. Tong, Tanya Symons, Lauren N. Ayton, Tessa Saunders

    Accessible and inclusive informed consent processes are crucial for ethical clinical research, yet little is known about how research staff implement these practices in Australia. This study aimed to explore current practice and perspectives of staff involved in informed consent processes for clinical research in Australia, including perceived barriers and enablers to facilitating accessible informed consent. To address this aim, we conducted a convergent parallel, mixed-methods study involving an online survey and semi-structured interviews (August to December 2024). Quantitative data were reported descriptively, while qualitative data were analysed using content analysis, with barriers and facilitators mapped to the Theoretical Domains Framework. Findings show that staff are motivated to employ a range of strategies to support their informed consent practice. The most frequently perceived facilitator to practice was providing information in varied formats, including the availability of video, audio, and language translations. However, there are challenges in offering information in multiple accessible formats due to limited skills, capability and resources (e.g. time, funding) to produce them. Industry leaders, regulators, funders and research organisations must lead and resource the delivery of accessible informed consent with focussed research staff training, funding accessibility, simplifying materials, promoting alternative formats, updating ethics guidance and convening shared-learning collaboratives with research participants to build sector confidence and ensure equitable, empowered consent.


  • Open Access

    Meeting Accessibility and Inclusion Needs in Clinical Research Through Lived Experience and Community Partnerships

    by Fleur O’HAre, Lauren Ayton, Tessa Saunders, David Foran, John Paul Cruz, Kevin Lee, Debra Simons, Grace King, Michael Burmeister, Shane Somerville, et al.

    Accessible and inclusive research practices are essential to support equitable participation in clinical research, yet barriers remain, particularly for people with vision impairment. While international and national guidance increasingly emphasise early and sustained involvement of individuals with lived experience in research design and conduct, there is limited empirical evidence detailing how such involvement can be operationalised across the research life cycle to improve accessibility in practice. This article describes the Meeting Access and Inclusion Needs (MAIN) project as a staged, pragmatic, and participatory methodology for integrating lived experience knowledge with implementation science across a multi-stage accessibility research program. Guided by an implementation science approach, the project combined qualitative methods, experience-based co-design, and iterative usability testing. Drawing on constructivist assumptions, knowledge was developed through collaboration among Research Partners with lived experience, disability advocates, research participants, research staff and researchers. Evidence was generated through a systematic review, surveys, interviews, focus groups, co-design workshops, and user experience testing involving people with lived experience of vision impairment alongside clinical research staff. Research Partners contributed across all stages as reviewers, co-designers, testers, and knowledge translators, while remaining distinct from research participants who generated primary empirical data. The project produced a suite of accessibility-focused outputs, including co-developed information templates, user guides, and implementation recommendations, refined through independent accessibility assessment by Vision Australia. Findings demonstrate that embedding lived experience knowledge at key decision points supports translation of accessibility principles into actionable improvement in informed consent processes and broader clinical research practices. This work extends the evidence base for experience-based participatory research involving people with vision impairment and a broader range of access requirements. It presents a transferable methodological model for integrating lived experience perspectives, research partnerships, and implementation science to strengthen accessible and inclusive research participation.

  • Open Access

    PROTOCOL: Strategies to Enhance Inclusion in Informed Consent Practice for People With Vision and/or Hearing Support Needs: A Systematic Review

    by Fleur O'HAre, Sujani Thrimawithana, Aimee Clague, Eden G. Robertson, David Foran, Caroline Ondracek, Camille Paynter, Tessa Saunders, Lauren N. Ayton

    An equitable and accessible informed consent process is needed to support agency and mutual decision-making. This systematic review aims to gather and characterise the evidence supporting methods that enhance inclusion and accessibility in informed consent practice for people with vision and/or hearing support needs. It will address the research question: what strategies are being used to enhance inclusive consent practice for people with vision impairment, people who are d/Deaf or hard of hearing, and people who are d/Deafblind. Additionally, the review aims to generate recommendations to facilitate the uptake of accessibility practices within informed consent procedures. This systematic review will build on current evidence for the positive impact of intentional actions to support accessible communication and information exchange. It may guide future work on intervention development and primary research in improving equity in clinical care and research.


  • Australia’s best practice guidelines for information access in the informed consent process for people with vision impairment: A scoping review using the AACTT framework

    by Fleur O’hAre, Camille Paynter, David Foran, Maria Kolic, Caroline Ondracek, Tessa Saunders, Lauren N. Ayton

    Background: Providing accessible information during informed consent practice helps people make important decisions about research participation. The aim of this review is to critically appraise the current Australian clinical research guidelines to assess their guidance on delivering accessible informed consent processes for people with vision impairment. Methods: An archival search of the Overton database was conducted for policy documents and guidelines pertaining to informed consent practice in Australia. This was cross checked with the Australian Research Council’s online catalogue of national codes and guidelines. Content analysis was performed using an implementation science framework to code the actors, actions, context, target and time (AACTT) elements of informed consent practice. The AACTT framework enables a detailed specification of the behaviours targeted for championing or change. Results: Ten policy documents specific to conducting consent procedures for clinical research or healthcare participation in Australia were identified and included in this review. Five of the 10 guidelines provided sufficient detail for researchers to know what actions to perform to enable inclusive consent practice and mutual engagement with people with vision impairment. However, they varied in their content describing how and when to perform them. Two of the key reference documents for clinical research conduct in Australia entirely lacked recommendations for accessible informed consent practice. Conclusions: Australian research policy and practice documents offer some direction in helping researchers to deliver accessible informed consent practice. However, guidelines produced by peak disability bodies and patient advocacy groups offer more direction on how to engage people with vision impairment and offer useful templates for producing accessible print materials.

  • Open Access

    Strategies to enhance inclusion in informed consent practice for people with sensory impairment: methods for a systematic literature review.

    by Fleur O'Hare, Sujani Thrimawithana, Aimee Clague, Camille Paynter, David Foran, Tessa Saunders, Lauren Ayton

    An equitable and accessible informed consent process is needed to support people with vision and hearing disability to make independent health decisions. Research and health service providers need to make deliberate and intentional efforts to ensure that communications and information provision meet the needs of the individual. Identification and evaluation of strategies to enhance agency during informed consent procedures for people with sensory impairment is needed. This systematic review will synthesize evidence on the most effective strategies to improve information accessibility and shared decision making for people with vision and hearing impairment in informed consent practice. In doing so, this review will produce recommendations for inclusive practice and guide future work on intervention development and primary research in improving equity and inclusion in health care and clinical research.

  • Open Access

    Awareness of Usher Syndrome and the Need for Multidisciplinary Care: A Cross-Occupational Survey of Allied Health Clinicians

    by Lauren N Ayton, Karyn L Galvin, Lauren Johansen, Fleur O'HAre, Emily R Shepard

    Background: Usher syndrome is the most common cause of deaf-blindness, affecting up to 1 in 6000 people. Multidisciplinary care is required to maximize outcomes for individuals and families. This study assessed awareness of Usher Syndrome amongst allied health clinicians who provide care related to the primarily affected senses of hearing and vision, ie, optometry, orthoptics and audiology. Methods: A prospective cross-sectional online survey of clinicians working in Australian university-affiliated clinics (7 optometry, 1 orthoptics and 4 audiology) was completed between September 2021 and January 2022. Questions were asked about the cause, common symptoms, and awareness of health professions who manage Usher syndrome. Results: The 27 audiologists, 40 optometrists, and 7 orthoptists who completed the survey included 53 females (71.6%), had an average age of 37 years (range 24– 70), and had an average duration of clinical experience of 13 years (range 1– 45 years). The majority of respondents correctly identified Usher syndrome as a genetic condition (86%), identified at least two of the affected senses (97%), and identified the progressive nature of the vision and hearing losses (> 90%). Awareness of vestibular dysfunction and its characteristics was low, as was knowledge of the key treatment roles that speech pathologists, genetic counsellors and geneticists play in the management of Usher Syndrome. The majority of respondents also did not identify important aspects of care within their own discipline. Conclusion: This study has shown that there is a need for targeted education to be delivered to hearing and vision care allied health clinicians to raise awareness of the vestibular impacts and aspects of vision loss experienced by people with Usher syndrome. This education needs to target the broad range of clinicians who have a key role in providing multidisciplinary care (including speech pathologists, geneticists, and genetic counsellors) and to identify the key aspects of good-quality multidisciplinary care.


  • Open Access

    Survey of perspectives of people with inherited retinal diseases on ocular gene therapy in Australia

    by Heather G. Mack, Alexis Ceecee Britten-Jones, Myra B. McGuinness, Fred K. Chen, John R. Grigg, Robyn V. Jamieson, Thomas L. Edwards, John De Roach, Fleur O’hAre, Keith R. Martin, et al.

    Many gene therapies are in development for treating people with inherited retinal diseases (IRD). We hypothesized that potential recipients of gene therapy would have knowledge gaps regarding treatment. We aimed to assess knowledge, attitudes, and perceptions of genetic therapies among potential recipients with IRD, using a novel instrument we designed (Attitudes to Gene Therapy-Eye (AGT-Eye)) and their associations with demographic data, self-reported visual status, and tools assessing quality of life and attitudes toward clinical trials using a community-based cross-sectional survey of Australian adults with IRD. AGT-Eye, overall quality of life EQ-5D-5L, National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) and Patient Attitudes to Clinical Trials (PACT-22) instruments were administered. Six hundred and eighty-one people completed the study, 51.7% women of mean age 53.5 years (SD ± 15.8). Most participants (91.6%) indicated they would likely accept gene therapy if it was available to them or family members. However, only 28.3% agreed that they had good knowledge of gene therapy. Most obtained information about gene therapy from the internet (49.3%). Respondents with post-graduate degrees scored highest compared to other educational levels on methods (p < 0.001) and outcomes (p = 0.003) and were more likely to see economic value of treatment (p = 0.043). Knowledge gaps were present regarding methods and outcomes of gene therapy. This survey has shown high level of interest in the IRD community for gene therapies, and highlights areas for improved clinician and patient education.


  • Open Access

    Victorian evolution of inherited retinal diseases natural history registry (VENTURE study): Rationale, methodology and initial participant characteristics

    by Alexis Ceecee Britten‐Jones, Fleur O'HAre, Thomas L. Edwards, Lauren N. Ayton, the VENTURE Study Consortium

    Background: Emerging treatments are being developed for inherited retinal diseases, requiring a clear understanding of natural progression and a database of potential participants for clinical trials. This article describes the rationale, study design and methodology of the Victorian Evolution of inherited retinal diseases NaTUral history REgistry (VENTURE), including data from the first 150 participants enrolled.Methods: VENTURE collects retrospective and prospective data from people with inherited retinal diseases. Following registration, participants are asked to attend a baseline examination using a standardised protocol to confirm their inherited retinal disease diagnosis. Examination procedures include (i) retinal function, using visual acuity and perimetry; (ii) retinal structure, using multimodal imaging and (iii) patient‐reported outcomes. Participants' molecular diagnoses are obtained from their clinical records or through targeted‐panel genetic testing by an independent laboratory. Phenotype and genotype data are used to enrol participants into disease‐specific longitudinal cohort sub‐studies.Results: From 7 July 2020 to 30 December 2021, VENTURE enrolled 150 registrants (138 families) and most (63%) have a rod‐cone dystrophy phenotype. From 93 participants who have received a probable molecular diagnosis, the most common affected genes are RPGR (13% of all registrants), USH2A (10%), CYP4V2 (7%), ABCA4 (5%), and CHM (5%). Most participants have early to moderate vision impairment, with over half (55%) having visual acuities of better than 6/60 (20/200) at registration.Conclusions: The VENTURE study will complement existing patient registries and help drive inherited retinal disease research in Australia, facilitating access to research opportunities for individuals with inherited retinal diseases.


  • The association of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio with retinal vein occlusion: a systematic review and meta‐analysis

    by Zhengyang Liu, Luke A. Perry, Jahan C. Penny‐Dimri, Dev Raveendran, Monica L. Hu, Janan Arslan, Alexis Ceecee Britten‐Jones, Fleur O’hAre, Lauren N. Ayton, Thomas L. Edwards

    The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) are emerging haematological inflammatory biomarkers. However, their significance in retinal vein occlusion (RVO) and its subtypes, branch and central RVO (BRVO and CRVO, respectively), is uncertain. This systematic review and meta‐analysis aimed to clarify the association of NLR and PLR with RVO. We searched MEDLINE (Ovid), EMBASE (Ovid) and the Cochrane Library for studies investigating the association of NLR and PLR with RVO from inception to 2 December 2020. We used random‐effects inverse‐variance modelling to generate pooled effect measures. We used bivariate Bayesian modelling to meta‐analyse the ability of NLR and PLR to differ between individuals with and without RVO and performed meta‐regression and sensitivity analyses to explore inter‐study heterogeneity. Eight studies published encompassing 1059 patients were included for analysis. Both NLR and PLR were significantly elevated in RVO, with pooled mean differences of 0.63 (95% confidence interval (CI) 0.31–0.95) and 21.49 (95% CI 10.03–32.95), respectively. The pooled sensitivity, specificity and area under the Bayesian summary receiver operating characteristic curve were, respectively, 0.629 (95% credible interval (CrI) 0.284–0.872), 0.731 (95% CrI 0.373–0.934) and 0.688 (95% CrI 0.358–0.872) for NLR; and 0.645 (95% CrI 0.456–0.779), 0.616 (95% CrI 0.428–0.761) and 0.621 (95% CrI 0.452–0.741) for PLR. Mean and variability of age and diabetes mellitus prevalence partially explained between‐study heterogeneity. NLR and PLR are significantly elevated in RVO. Future research is needed to investigate the potential prognostic value and independence of these findings.